Skip to main content
Pascal Geldsetzer, MD, Named a TIME100 World’s Most Influential Leader in Health

News

Science News February 11, 2026

Pascal Geldsetzer, MD, Named a TIME100 World’s Most Influential Leader in Health

By Communications Staff

Pascal’s research drove major 2025 health discoveries. His widely covered finding that shingles vaccination is linked to lower dementia risk drew global attention and reshaped healthcare thinking.

We’re incredibly proud to celebrate Pascal Geldsetzer, MD, PhD, who has been named to TIME's 2026 TIME100 Health List of the World’s Most Influential Leaders in Health.

These titans, innovators, leaders, pioneers, and catalysts named by TIME have pushed new ideas — from gene therapies to regulatory agencies — ahead to build healthier populations around the world.

Geldsetzer, MD, PhD, is an Assistant Professor of Medicine in Primary Care and Population Health at Stanford, with a courtesy appointment in Epidemiology and Population Health. His research focuses on finding practical, high-impact ways to improve health as people age, using large-scale health data to answer questions that traditional clinical trials often can’t.

Geldsetzer is especially known for his work using natural experiments (real-world policy changes and health system rollouts) to uncover cause-and-effect relationships in population health.

In 2025, he led landmark studies showing that shingles vaccination is associated with a lower risk of dementia and may slow disease progression, offering new insight into the role of immune and viral pathways in neurodegenerative disease, and ultimately, changing how we think about healthcare.  

Check out his work featured by numerous high impact outlets.

Scientific American cover art with a scientist looking in a microscope.
Scientific American

10 Discoveries That Transformed How We Thought about Health in 2025

JAMA research of the year.
JAMA

Top Neurology Studies of 2025

New York Times cover art of half a young face with chicken pox and an elderly face with shingles.
New York Times

Shingles Vaccine Can Reduce Risk of Dimentia

Two vials of shingles vaccines.
NBC News

Shingles Vaccine May Protect Against Dementia, New Study Suggests

A sillhouette of a face looking to the left.
Stanford Medicine Coverage

For Those With Dementia, New Study Suggests Shingles Vaccine Could Slow the Disease

A medical professional removing a single vial of shingles vaccine from a box.
CNN

Shingles Vaccine May Slow Progression of Dementia, New Study Suggests

About Stanford Department of Medicine

Stanford Department of Medicine is an academic department within the Stanford School of Medicine dedicated to advancing patient care, education, and research across internal medicine and its subspecialties. We provide high‑quality patient care, train doctors and scientists, and do research to prevent illness, improve diagnosis and treatment, and help people live healthier lives. We serve diverse communities and work to make health care better for today and tomorrow. For more information, visit medicine.stanford.edu

Communications Staff

The Central Communications Team is the Department of Medicine's in-house team of writers, editors, and creatives dedicated to telling the stories that matter across our community. From research discoveries and program highlights to faculty milestones and trainee achievements, we cover the people and moments that define the department.